rs3024866

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003151.4(STAT4):​c.1113-4C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.698 in 1,613,274 control chromosomes in the GnomAD database, including 406,290 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.57 ( 28572 hom., cov: 31)
Exomes 𝑓: 0.71 ( 377718 hom. )

Consequence

STAT4
NM_003151.4 splice_region, intron

Scores

2
Splicing: ADA: 0.0006460
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.0620

Publications

37 publications found
Variant links:
Genes affected
STAT4 (HGNC:11365): (signal transducer and activator of transcription 4) The protein encoded by this gene is a member of the STAT family of transcription factors. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. This protein is essential for mediating responses to IL12 in lymphocytes, and regulating the differentiation of T helper cells. Mutations in this gene may be associated with systemic lupus erythematosus and rheumatoid arthritis. Alternate splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Aug 2011]
STAT4 Gene-Disease associations (from GenCC):
  • systemic lupus erythematosus
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet
  • disabling pansclerotic morphea of childhood
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 2-191058115-G-A is Benign according to our data. Variant chr2-191058115-G-A is described in ClinVar as Benign. ClinVar VariationId is 403495.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.744 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STAT4NM_003151.4 linkc.1113-4C>T splice_region_variant, intron_variant Intron 12 of 23 ENST00000392320.7 NP_003142.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STAT4ENST00000392320.7 linkc.1113-4C>T splice_region_variant, intron_variant Intron 12 of 23 1 NM_003151.4 ENSP00000376134.2

Frequencies

GnomAD3 genomes
AF:
0.569
AC:
86371
AN:
151806
Hom.:
28577
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.220
Gnomad AMI
AF:
0.813
Gnomad AMR
AF:
0.553
Gnomad ASJ
AF:
0.686
Gnomad EAS
AF:
0.530
Gnomad SAS
AF:
0.674
Gnomad FIN
AF:
0.700
Gnomad MID
AF:
0.617
Gnomad NFE
AF:
0.749
Gnomad OTH
AF:
0.602
GnomAD2 exomes
AF:
0.642
AC:
160976
AN:
250916
AF XY:
0.657
show subpopulations
Gnomad AFR exome
AF:
0.210
Gnomad AMR exome
AF:
0.512
Gnomad ASJ exome
AF:
0.665
Gnomad EAS exome
AF:
0.517
Gnomad FIN exome
AF:
0.692
Gnomad NFE exome
AF:
0.744
Gnomad OTH exome
AF:
0.667
GnomAD4 exome
AF:
0.712
AC:
1040434
AN:
1461350
Hom.:
377718
Cov.:
42
AF XY:
0.712
AC XY:
517871
AN XY:
727016
show subpopulations
African (AFR)
AF:
0.198
AC:
6638
AN:
33472
American (AMR)
AF:
0.517
AC:
23104
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.669
AC:
17475
AN:
26128
East Asian (EAS)
AF:
0.556
AC:
22030
AN:
39650
South Asian (SAS)
AF:
0.659
AC:
56831
AN:
86246
European-Finnish (FIN)
AF:
0.694
AC:
37054
AN:
53412
Middle Eastern (MID)
AF:
0.621
AC:
3581
AN:
5766
European-Non Finnish (NFE)
AF:
0.749
AC:
832861
AN:
1111586
Other (OTH)
AF:
0.677
AC:
40860
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
14959
29918
44877
59836
74795
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20046
40092
60138
80184
100230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.569
AC:
86369
AN:
151924
Hom.:
28572
Cov.:
31
AF XY:
0.568
AC XY:
42203
AN XY:
74244
show subpopulations
African (AFR)
AF:
0.219
AC:
9073
AN:
41374
American (AMR)
AF:
0.553
AC:
8435
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.686
AC:
2382
AN:
3470
East Asian (EAS)
AF:
0.530
AC:
2745
AN:
5182
South Asian (SAS)
AF:
0.675
AC:
3257
AN:
4822
European-Finnish (FIN)
AF:
0.700
AC:
7379
AN:
10538
Middle Eastern (MID)
AF:
0.622
AC:
183
AN:
294
European-Non Finnish (NFE)
AF:
0.749
AC:
50913
AN:
67966
Other (OTH)
AF:
0.600
AC:
1264
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1495
2990
4486
5981
7476
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
718
1436
2154
2872
3590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.683
Hom.:
55817
Bravo
AF:
0.540
Asia WGS
AF:
0.559
AC:
1945
AN:
3478
EpiCase
AF:
0.740
EpiControl
AF:
0.737

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
9.7
DANN
Benign
0.78
PhyloP100
-0.062
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00065
dbscSNV1_RF
Benign
0.060
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3024866; hg19: chr2-191922841; COSMIC: COSV61831638; API